Napabucasin
Term · Oncology and biomedicine · MLC-T-ONC-015434
An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated, napabucasin appears to target and inhibit multiple pathways involved in cancer cell stemness. This may ultimately inhibit cancer stemness cell (CSC) growth as well as heterogeneous cancer cell growth. CSCs, self-replicating cells that are able to differentiate into heterogeneous cancer cells, appear to be responsible for the malignant growth, recurrence and resistance to conventional chemotherapies.
| Identifier | MLC-T-ONC-015434 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | cancer stemness inhibitor BBI608 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015434",
"term": "Napabucasin",
"field": "Oncology and biomedicine",
"definition": "An orally available cancer cell stemness inhibitor with potential antineoplastic activity. Even though the exact target has yet to be fully elucidated, napabucasin appears to target and inhibit multiple pathways involved in cancer cell stemness. This may ultimately inhibit cancer stemness cell (CSC) growth as well as heterogeneous cancer cell growth. CSCs, self-replicating cells that are able to differentiate into heterogeneous cancer cells, appear to be responsible for the malignant growth, recurrence and resistance to conventional chemotherapies.",
"synonyms": [
"cancer stemness inhibitor BBI608"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/napabucasin/"
}
Record 11,589 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.